Help guide our efforts to modernize
Send us your comments by March 14, 2020. Menu

Filgotinib Versus Placebo in Adults With Active Rheumatoid Arthritis (RA) Who Have an Inadequate Response to Biologic Disease-modifying Anti-rheumatic Drug(s) (DMARDs) Treatment (FINCH 2)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02873936
Recruitment Status : Completed
First Posted : August 22, 2016
Last Update Posted : March 18, 2019
Galapagos NV
Information provided by (Responsible Party):
Gilead Sciences

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : March 20, 2018
Actual Study Completion Date : June 26, 2018
Certification/Extension First Submitted : March 13, 2019